首页> 美国卫生研究院文献>International Orthopaedics >Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma
【2h】

Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma

机译:基因芯片分析鉴定与人类骨肉瘤组织学亚型相关的独特基因表达谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteosarcoma is the most common primary malignant bone tumour. Currently osteosarcoma classification is based on histological appearance. It was the aim of this study to use a more systematic approach to osteosarcoma classification based on gene expression analysis and to identify subtype specific differentially expressed genes. We analysed the global gene expression profiles of ten osteosarcoma samples using Affymetrix U133A arrays (five osteoblastic and five non-osteoblastic osteosarcoma patients). Differential gene expression analysis yielded 75 genes up-regulated and 97 genes down-regulated in osteoblastic versus non-osteoblastic osteosarcoma samples, respectively. These included genes involved in cell growth, chemotherapy resistance, angiogenesis, steroid- and neuropeptide hormone receptor activity, acute-phase response and serotonin receptor activity and members of the Wnt/ß-catenin pathway and many others. Furthermore, we validated the highly differential expression of six genes including angiopoietin 1, IGFBP3, ferredoxin 1, BMP, decorin, and fibulin 1 in osteoblastic osteosarcoma relative to non-osteoblastic osteosarcoma. Our results show the utility of gene expression analysis to study osteosarcoma subtypes, and we identified several genes that may play a role as potential therapeutic targets in the future.
机译:骨肉瘤是最常见的原发性恶性骨肿瘤。目前,骨肉瘤的分类是基于组织学外观。这项研究的目的是基于基因表达分析,采用更系统的方法对骨肉瘤进行分类,并鉴定亚型特异性差异表达基因。我们使用Affymetrix U133A阵列(5名成骨细胞和5名非成骨细胞性骨肉瘤患者)分析了十个骨肉瘤样品的全球基因表达谱。差异基因表达分析在成骨细胞与非成骨细胞性骨肉瘤样品中分别产生了75个基因上调和97个基因下调。这些基因包括与细胞生长,化疗耐药性,血管生成,类固醇和神经肽激素受体活性,急性期反应和血清素受体活性有关的基因,以及Wnt /β-catenin途径的成员等。此外,我们验证了成骨细胞肉瘤相对于非成骨细胞肉瘤的六个基因(包括血管生成素1,IGFBP3,铁氧还蛋白1,BMP,除蛋白和纤维蛋白1)的高度差异表达。我们的结果显示了基因表达分析在研究骨肉瘤亚型中的实用性,并且我们鉴定了几种可能在将来充当潜在治疗靶标的基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号